Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$13.85
-1.5%
$13.26
$12.00
$18.68
$85.87M0.9918,654 shs3,166 shs
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$10.57
-1.1%
$8.25
$3.81
$37.50
$14.05M-0.01187,309 shs14,967 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.42
-2.2%
$2.52
$0.82
$3.38
$87.86M1.143.48 million shs472,154 shs
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$2.90
-1.1%
$2.69
$1.92
$4.21
$101.90M0.41247,812 shs13,313 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
0.00%-3.03%-0.50%+1.59%-7.92%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
0.00%-9.87%+121.58%+22.06%-17.47%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%-0.40%-5.73%+45.29%+142.16%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.00%+11.41%+6.16%-7.86%+39.52%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
0.8803 of 5 stars
0.03.00.00.00.60.81.9
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3.115 of 5 stars
3.24.00.00.04.01.70.6
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.1543 of 5 stars
3.52.00.00.03.20.00.6
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
2.2 of 5 stars
3.83.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.33
Hold$100.00846.52% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00272.67% Upside
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.4086.27% Upside

Current Analyst Ratings Breakdown

Latest LYRA, MGRM, MBOT, and FONR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.83$3.03 per share4.57$24.78 per share0.56
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$1.53M9.18N/AN/A$8.86 per share1.19
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$370K279.64N/AN/A$0.42 per share6.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2511.08N/A8.19%5.31%3.97%N/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/12/2025 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$16.33M-$0.45N/AN/AN/AN/A-115.71%-92.75%8/13/2025 (Estimated)

Latest LYRA, MGRM, MBOT, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/14/2025Q1 2025
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
5/6/2025Q1 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
2.96
2.96
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.00
7.00

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
95.62%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3.25%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
501.33 million1.28 millionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million25.66 millionNot Optionable

Recent News About These Companies

Monogram Orthopaedics announces 510(k) clearance for mBos TKA System

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$13.85 -0.21 (-1.49%)
As of 11:24 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$10.56 -0.12 (-1.08%)
As of 11:24 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.42 -0.06 (-2.23%)
As of 11:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.90 -0.03 (-1.06%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.